The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.82
Bid: 7.80
Ask: 7.96
Change: 0.08 (1.03%)
Spread: 0.16 (2.051%)
Open: 7.80
High: 7.82
Low: 7.70
Prev. Close: 7.80
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: James Cropper falls on lower outlook

Wed, 17th Jan 2024 10:24

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Frontier Developments PLC, up 17% at 138.24 pence, 12-month range 95.00p-649.00p. The video games developer and publisher reports its interim results for the six months ended November 30. Revenue falls to GBP47.7 million from GBP57.1 million a year earlier. Swings to pretax loss of GBP33.1 million, versus a profit of GBP6.7 million. Looking ahead, Frontier says total sales during the important trading period of late November to early January were in-line with expectations. It continues to expects full year revenue to be in line with guidance of GBP80 million to GBP95 million. "2023 was a challenging year for Frontier and for many companies across the games industry. The last few months have been a tough period of change for everyone at Frontier, and of course it's been particularly difficult for those people in teams who have suffered redundancies," says Chief Executive Jonny Watts.

----------

AIM - LOSERS

----------

James Cropper PLC, down 33% to 535.00p, 12-month range 521.50p-960.00p. James Cropper says it expects profit for financial 2024 to fall short of expectations after facing delays in the final months of the year, and eyes a lower revenue. The paper, packaging and advanced materials' manufacturer's financial year ends April 1. James Cropper expects adjusted pretax profit to be "materially below" expectations. In financial 2023, adjusted pretax profit was GBP3.2 million. In addition, revenue for the financial year is expected to be no less than GBP103 million, down from GBP129.7 million the year prior.

----------

Oxford BioDynamics PLC, down 23% to 26.24p, 12-month range 9.20p-52.00p. The biotechnology company reports interim results for six months ended September 30. Reports a jump in revenue to GBP510,000 from GBP154,000 a year earlier. Pretax loss widens, however, to GBP11.4 million from GBP7.6 million a year earlier "This year we again made significant, rapid progress in the transformation of OBD that began with our expanded strategy in late 2020," CEO Jon Burrows comments. Looking ahead, he said: "This year, we are dedicated to growing sales of both EpiSwitch CiRT and EpiSwitch PSE across all our markets and channels and to pursuing opportunities to monetize assets from within our pipeline of deployable tests."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
21 May 2019 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 22 May Marks & Spencer GroupFull Year ResultsRoyal MailFull Year Year Year

Read more
3 May 2019 14:19

Oxford BioDynamics Chosen To Join ALS Biomarker Study

LONDON (Alliance News) - Oxford Biodynamics PLC said on Friday it has joined the REFINE-ALS study, designed to identify specific biomarkers in people with amyotrophic lateral sclerosis.The

Read more
23 Apr 2019 10:33

Three AIM firms celebrate Queen's Award for Enterprise wins

(Sharecast News) - Three firms trading on London's AIM market were celebrating wins in the Queen's Award for Enterprise on Tuesday, with Inspiration Healthcare, Ergomed and Oxford BioDynamics all picking up the accolades.

Read more
5 Apr 2019 11:25

Oxford BioDynamics Appoints Non-Executive Director As Interim Chair

LONDON (Alliance News) - Oxford BioDynamics PLC said on Friday it has promoted Non-Executive Director Steven Wiggle as interim chair with immediate effect.Wiggle will be replacing David who

Read more
2 Apr 2019 12:08

Oxford BioDynamics Launches US Business With New Commerical Head

LONDON (Alliance News) - Biotechnology firm Oxford BioDynamics PLC said Tuesday it has established a US subsidiary and appointed a commercial head for the country.In line with its strategy

Read more
19 Mar 2019 11:54

Oxford BioDynamics EpiSwitch Test Included In Cancer Screening Study

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday said it has signed an agreement for its EpiSwitch test to be used by Imperial College London in a prostate cancer screening College is to

Read more
19 Mar 2019 11:43

Oxford BioDynamics biomarker to be used in prostate cancer test trial

(Sharecast News) - Oxford BioDynamics announced on Tuesday that it has signed an agreement with Imperial College London, to utilise its latest 'EpiSwitch' biomarker signature for the blood-based diagnosis of prostate cancer in the 'PROSTAGRAM' trial.

Read more
15 Feb 2019 14:55

DIRECTOR DEALINGS: Oxford BioDynamics Non-Exec's Associate Buys Shares

LONDON (Alliance News) - Oxford BioDynamics PLC on Friday said that the Vulpie Life Sciences Fund, controlled by Non-Executive Director Steven Diggle, purchased nearly GBP37,000 in stock over two

Read more
11 Jan 2019 10:21

Oxford Biodynamics Chair And Long-Serving Non-Exec To Stand Down

LONDON (Alliance News) - Biotechnology company Oxford Biodynamics PLC said Friday Chair David Williams and Non-Executive Director Alison Kibble will stand down later in 2019.Williams - 2016

Read more
11 Dec 2018 11:47

Oxford BioDynamics Annual Loss Narrows On Lower Costs

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday reported a sharply narrowed annual loss due to absence of initial public offering related costs.For the year ended September 30, a

Read more
29 Aug 2018 17:03

GL Healthcare Holds 5% Oxford Biodynamics Stake After Deal (ALLISS)

LONDON (Alliance News) - Oxford Biodynamics PLC said Wednesday that GL Healthcare Investment LP holds a 5.1% stake in the biotechnology company after a transaction on Tuesday.GL holding the

Read more
22 Aug 2018 10:26

Chinese Investor Chooses Oxford BioDynamics As First European Partner (ALLISS)

LONDON (Alliance News) - Oxford BioDynamics PLC on Wednesday said a Chinese investment management firm has invested GBP9.8 million in the company.GL Capital Group, which focuses on firms, a

Read more
22 Aug 2018 08:39

Oxford BioDynamics sets sights on China following GL investment

(Sharecast News) - AIM-listed biotechnology company Oxford BioDynamics has launched a strategic partnership with GL Capital, a Chinese healthcare-focused investment group.

Read more
22 May 2018 14:06

Oxford BioDynamics Interim Loss Narrows On Increased Revenue

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday reported a narrowed first half loss on the back of increase in revenue.The epigenetic biomarker developer recorded a pretax loss a

Read more
15 May 2018 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 16 May C&C GroupFull Year ResultsBurberry GroupFull Year & Year Year 17

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.